SCHEMBL10690521

SCHEMBL10690521

CC(N1CCCC1)N1CCc2c([nH]c3ccccc23)C(CO)C1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
ABCB1 P08183 2/20 0.45
ABCG2 Q9UNQ0 2/20 0.45
ESR1 P03372 1/20 0.44
PGR P06401 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 2/20 0.43
MAPT P10636 2/20 0.43
BRD3 Q15059 1/20 0.42
POLB P06746 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CHRNA7 P36544 1/20 0.41
SLC6A4 P31645 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10686635 0.99 ADRA1D (0.48) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10690877 0.90 KDM4E (0.48) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10681418 0.84 ADRA1D (0.49) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10687983 0.82 ADRA1D (0.47) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10688707 0.81 ADRA1D (0.56) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10690528 0.79 SIGMAR1 (0.56) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10686306 0.79 ADRA1D (0.53) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10686642 0.78 SIGMAR1 (0.55) ADRA1DADRA1AADRA1BABCB1ABCG2
SCHEMBL10685213 0.77 ADRA1D (0.51) ADRA1DADRA1AADRA1BESR1PGR
SCHEMBL10682913 0.74 ACHE (0.54) ADRA1DADRA1AADRA1BABCB1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4719208-A 1,2,3,4,5,6-hexahydroazepino(4,5-B)indole derivatives, their preparation, intermediate compounds, and their application in therapeutics OMNICHEM SOCIETE ANONYME (BE) 1988-01-12 US disclosed